Cannalink, Inc. (CNLK) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cannalink, Inc. (CNLK) trades at $0.0002. Cannalink, Inc. is a development stage company focused on cannabidiol (CBD) based products and services for the medical marijuana and industrial healthcare sectors. Sector: Technology.
Price as of Aug 20, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for CNLK: CNLK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CNLK against Technology peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CNLK: 2/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Cannalink, Inc. (CNLK) Technology Profile & Competitive Position
Cannalink, Inc., a development stage company based in San Diego, targets the medical marijuana and industrial healthcare sectors by intending to develop cannabidiol (CBD) products and providing services to emerging companies. The company operates within the technology sector, specifically in information technology services.
What Is the Investment Thesis for CNLK?
Cannalink, Inc. presents a high-risk, high-reward investment opportunity given its development stage status and focus on the emerging medical marijuana and industrial healthcare sectors. The company's success hinges on its ability to develop viable CBD products and secure clients in a rapidly evolving regulatory environment. Key value drivers include successful product development, strategic partnerships, and effective market penetration. Potential catalysts include regulatory changes favorable to the cannabis industry and increasing acceptance of CBD products. Investors should carefully consider the risks associated with investing in a development stage company in a highly regulated and competitive market. The company's beta of 1.22 suggests higher volatility compared to the broader market.
Based on FMP financials and quantitative analysis
CNLK Key Highlights
Cannalink, Inc. is a development stage company focused on the medical marijuana and industrial healthcare sectors.
- The company intends to develop cannabidiol (CBD) based products.
- Cannalink aims to provide services to emerging companies in its target sectors.
- The company is based in San Diego, California, a state with a mature cannabis market.
- Cannalink's beta is 1.22, indicating higher volatility.
Who Are CNLK's Competitors?
CNLK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| IBM International Business Machines Corporation | $234.74 | -1.02% | $221B | 60 |
| ACN Accenture plc | $181.35 | -0.99% | $111B | 80 |
| CTSH Cognizant Technology Solutions Corporation | $60.92 | -0.02% | $27.4B | 85 |
| FISV Fiserv, Inc. | $51.38 | -1.33% | $27.4B | 57 |
| BR Broadridge Financial Solutions, Inc. | $177.80 | +1.01% | $20.6B | 67 |
| LDOS Leidos Holdings, Inc. | $140.46 | -4.00% | $17.7B | 69 |
| CDW CDW Corporation | $137.20 | +1.65% | $17.5B | 64 |
| CACI CACI International Inc | $646.35 | -2.46% | $14.3B | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CNLK's Key Strengths?
Focus on high-growth medical marijuana and industrial healthcare sectors
- Potential for innovative CBD product development
- Location in a state with a mature cannabis market
What Are CNLK's Weaknesses?
Development stage company with limited operating history
- Dependence on regulatory approvals and market acceptance
- Intense competition from established players
What Could Drive CNLK Stock Higher?
Potential regulatory changes favorable to the cannabis industry.
- Increasing acceptance and adoption of CBD products.
- Development and launch of new CBD product lines.
What Are the Key Risks for CNLK?
Changing regulations and legal landscape could negatively impact operations.
- Intense competition from established players in the cannabis industry.
- Fluctuations in raw material prices could affect profitability.
- Negative publicity or health concerns related to CBD products.
- Limited operating history as a development stage company.
What Are the Growth Opportunities for CNLK?
- Expansion into new CBD product lines: Cannalink can capitalize on the growing demand for CBD products by developing new formulations, delivery methods, and applications. Success depends on research and development efforts and effective marketing strategies.
- Strategic partnerships with medical marijuana companies: Cannalink can forge strategic alliances with established medical marijuana companies to gain access to their distribution networks, customer base, and industry expertise. These partnerships can accelerate Cannalink's market entry and enhance its credibility within the sector. Collaboration can involve joint product development, co-marketing initiatives, and cross-promotion activities.
- Geographic expansion into new markets: Cannalink can expand its operations into new states and countries that have legalized medical marijuana and CBD products. This geographic diversification can reduce Cannalink's reliance on a single market and increase its overall growth potential. Expansion requires careful consideration of local regulations, market dynamics, and competitive landscape.
- Development of technology solutions for the cannabis industry: Cannalink can leverage its technology expertise to develop innovative software and hardware solutions for the cannabis industry. These solutions can address various needs, such as inventory management, compliance tracking, and patient monitoring. The market for cannabis technology is growing rapidly, offering significant opportunities for Cannalink to generate revenue and establish itself as a technology leader.
- Provision of consulting services to emerging cannabis companies: Cannalink can offer consulting services to emerging cannabis companies, providing guidance on business strategy, regulatory compliance, and operational efficiency. These services can generate a steady stream of revenue and establish Cannalink as a trusted advisor within the industry. Consulting engagements can cover a wide range of topics, such as market analysis, financial planning, and risk management.
What Are CNLK's Competitive Advantages?
- First-mover advantage in a niche market
- Proprietary technology for CBD product development
- Strong relationships with medical marijuana companies
What Does CNLK Do?
Cannalink, Inc., based in San Diego, California, is a development stage company with intentions to develop cannabidiol (CBD) based products and offer services to emerging businesses within the medical marijuana and industrial healthcare sectors. As a development stage entity, Cannalink is in the initial phases of establishing its operations and market presence. The company's focus on CBD products aligns with the growing demand and acceptance of cannabis-related products for medicinal and therapeutic purposes. Cannalink aims to support emerging companies in the medical marijuana sector by providing essential services, potentially including technology solutions, consulting, and product development assistance. The company's geographic location in San Diego, California, positions it within a state that has a well-established cannabis industry, providing access to resources, expertise, and potential partnerships. Cannalink's success will depend on its ability to develop innovative CBD products, establish a strong network of clients in the medical marijuana sector, and navigate the regulatory landscape effectively.
What Products and Services Does CNLK Offer?
- Develop cannabidiol (CBD) based products
- Provide services to emerging companies in the medical marijuana sector
- Offer services to emerging companies in the industrial healthcare sector
- Operate as a development stage company
- Focus on the cannabis industry
- Based in San Diego, California
How Does CNLK Make Money?
- Develop and sell CBD-based products
- Provide technology and consulting services to cannabis companies
- Generate revenue through product sales and service fees
What Industry Does CNLK Operate In?
Cannalink, Inc. operates within the burgeoning medical marijuana and industrial healthcare sectors, which are experiencing significant growth due to increasing legalization and acceptance of cannabis-based products. The market is characterized by intense competition, evolving regulations, and rapid technological advancements. Cannalink's success depends on its ability to differentiate itself through innovative products, strategic partnerships, and effective market penetration. The company must navigate the complex regulatory landscape and adapt to changing consumer preferences to thrive in this dynamic industry. The information technology services sector is also competitive, requiring Cannalink to offer unique value to its clients.
Who Are CNLK's Key Customers?
- Emerging companies in the medical marijuana sector
- Emerging companies in the industrial healthcare sector
- Consumers seeking CBD-based products
Company Profile
Cannalink, Inc. operates in the Information Technology Services industry within the Technology sector. It is headquartered in San Diego, US. The company is led by CEO Richard Smith. CNLK has traded publicly since 1998.
Key Financial Metrics
Return on equity for Cannalink, Inc. stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. CNLK trades at a trailing price-to-earnings ratio of 0.00, below the Technology sector average of ~34x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
CNLK Financials
Bull Case vs Bear Case
Bull Case
- CannaLink has seen a surge in insider buying recently, indicating confidence from leadership in the company's future prospects.
- Community sentiment has shifted positively with increasing discussions around CannaLink's innovative approach in the cannabis supply chain.
- Recent partnerships with key industry players have strengthened its market position, attracting attention from both investors and analysts.
- The growing acceptance of cannabis products in various markets has led to a favorable outlook, boosting investor enthusiasm.
Bear Case
- Despite the positive sentiment, regulatory uncertainties in the cannabis sector continue to pose risks that may deter potential investors.
- There has been a noticeable increase in bearish discussions within the community, with some expressing concerns over the company's scalability.
- Recent financial reports revealed challenges in meeting growth expectations, leading to skepticism about future performance.
- Market competition is intensifying, with new entrants potentially impacting CannaLink's market share and profitability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
CNLK Latest News
No recent news available for CNLK.
CNLK Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CNLK.
Price Targets
Wall Street price target analysis for CNLK.
CNLK MoonshotScore
What does this score mean?
The MoonshotScore rates CNLK 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Richard Smith
CEO
Information on Richard Smith's background is not available in the provided data. Therefore, his career history, education, previous roles, and credentials are Unknown.
Track Record: Information on Richard Smith's track record is not available in the provided data. Key achievements, strategic decisions, and company milestones under his leadership are Unknown.
CNLK OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Cannalink, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors and may be subject to greater risks compared to companies listed on national exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks requires a higher degree of due diligence and risk tolerance due to the potential for limited liquidity, price volatility, and information asymmetry.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency
- Higher risk of fraud and manipulation
- Lower liquidity and higher price volatility
- Potential for delisting or suspension of trading
- Limited regulatory oversight
- Verify the company's registration and legal status
- Review available financial statements and disclosures
- Assess the company's business model and competitive landscape
- Evaluate the management team and their track record
- Understand the risks associated with investing in OTC stocks
- Monitor trading volume and price activity
- Consult with a financial advisor
- Independent audits of financial statements (if available)
- Presence of a qualified management team
- Clear business plan and strategy
- Positive news coverage or industry recognition
- Active investor relations and communication
Common Questions About CNLK (Technology)
What does Cannalink, Inc. do?
Cannalink, Inc. is a development stage company focused on developing cannabidiol (CBD) based products and providing services to emerging companies in the medical marijuana and industrial healthcare sectors. The company aims to capitalize on the growing demand for CBD products and the increasing number of businesses entering the cannabis industry.
What do analysts say about CNLK stock?
As a development stage company trading on the OTC market, Cannalink, Inc. likely has limited analyst coverage. Key valuation metrics and growth considerations are difficult to assess due to the company's limited operating history and financial disclosures. Investors should conduct their own thorough research and due diligence before investing in CNLK stock.
What are the main risks for CNLK?
Cannalink, Inc. faces several risks inherent to its development stage status and its focus on the cannabis industry. Regulatory changes and legal uncertainties pose a significant threat, as evolving laws could restrict the company's operations or limit the market for CBD products.
What are the key factors to evaluate for CNLK?
Evaluate CNLK on fundamentals, analyst consensus, and risk factors. Cannalink, Inc. presents a high-risk, high-reward investment opportunity given its development stage status and focus on the emerging medical marijuana and industrial healthcare sectors. Not financial advice.
How frequently does CNLK data refresh on this page?
CNLK's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven CNLK's recent stock price performance?
Cannalink, Inc. (CNLK) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on high-growth medical marijuana and industrial healthcare sectors. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CNLK overvalued or undervalued right now?
Cannalink, Inc. (CNLK) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research CNLK before investing?
Before investing in Cannalink, Inc. (CNLK), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on Cannalink, Inc. due to its development stage status and OTC listing.
- AI analysis pending for CNLK.